欧洲Europe
🇪🇺

欧盟European Union

统一框架下的分区评审,门槛高、数据全Zonal assessment under a unified framework — high bar, full data

主要作物Key Crops
谷物 / 果蔬 / 油橄榄 / 油菜Cereals / F&V / Olives / Rapeseed
农业占 GDPAgri GDP Share
约 2%~2%
核心产区Core Region
西欧 / 南欧 / 北欧W / S / N Europe
法规框架Framework
(EC) 1107/2009(EC) 1107/2009

01农业基本情况Agricultural Overview

市场规模、主要作物与农业结构Market scale, key crops and farm structure

欧盟农业以成员国差异化种植为主:法国、德国、波兰的大田谷物,西班牙、意大利的果蔬与橄榄油,北欧的根茎作物等。共同农业政策(CAP)塑造生产结构,对农药的环境与健康要求极为严格。EU agriculture is diverse by member state: grains in France, Germany, Poland; fruit, vegetables and olive oil in Spain, Italy; root crops in the North. The Common Agricultural Policy shapes production, with very strict environmental and health standards for pesticides.

  • 活性成分须先在欧盟层面获批准。Active ingredients must first be approved at EU level.
  • 制剂按北/中/南三区(zonal)评审。Formulations assessed by North/Central/South zones.
  • 削减使用、绿色协议的合规趋势明显。Clear trend toward use reduction under the Green Deal.

02农药基本情况Pesticide Overview

主管机构、登记制度与市场Authority, registration system and market

主管机构Regulatory Authority

风险评估由欧洲食品安全局(EFSA)与欧洲化学品管理局(ECHA)承担;欧盟委员会批准活性成分;各成员国主管机关(如德国 BVL、法国 ANSES)负责制剂分区登记。Risk assessment is done by EFSA and ECHA; the European Commission approves active ingredients; member-state authorities (e.g., Germany BVL, France ANSES) handle zonal formulation registration.

登记制度Registration System

依据 (EC) 1107/2009(植物保护产品)与 396/2005(MRL);活性成分需先获批,制剂再分区登记,数据可互认。Under (EC) 1107/2009 (plant protection products) and 396/2005 (MRLs); AI approved first, then zonal formulation registration with data mutual recognition.

市场概况Market Snapshot

全球高端、高门槛市场,单位价值高。A premium, high-bar market with high per-unit value.

  • 须有欧盟境内主体或授权代理。An EU-established entity or authorized agent is required.
  • 资料以英文为主,遵循 EU 统一格式。Mostly English dossiers per unified EU formats.
  • 原药获批是制剂登记的前置条件。AI approval is a prerequisite for formulation registration.

03登记注册门槛Registration Thresholds

取得欧盟登记的一般门槛(初稿,供参考):General thresholds for an EU registration (draft, for reference):

1申请人资格Eligibility

欧盟境内设立的主体或授权代理人。An EU-established entity or authorized agent.

2活性成分获批AI Approval

原药须列入欧盟批准清单或单独申请批准。AI must be on the EU approved list or seek approval.

3分区登记Zonal Dossier

选定成员国(RMS)牵头,其他区互认。Lead member state (RMS) reviews; other zones mutually recognize.

4全套数据Full Data

毒理、生态、残留、环境归趋与风险削减。Tox, eco, residue, fate and risk-mitigation data.

04登记周期与时间Registration Timeline

典型登记周期(仅供参考):Typical timeline (indicative):

活性成分批准AI Approval

约 3 年~3 years

若未在清单内,需先走批准程序。If not listed, the approval procedure comes first.

分区制剂评审Zonal Review

12–24+ 个月12–24+ months

RMS 评审,区内互认。RMS review with in-zone recognition.

成员国转化MS Transposition

1–6 个月1–6 months

各国发放本国登记证。Each state issues its national certificate.

提示Note:活性成分已获批时,制剂分区登记整体约 1.5–3 年。When the AI is already approved, zonal formulation registration is ~1.5–3 years.

05联系我们Contact Us

该国本地办公室与对接人Local office and point of contact for this market

🏢
办公室Office · 欧盟办公室(总部)· 欧盟业务部EU Office (HQ) · EU Desk
保加利亚普罗夫迪夫 察尔·阿森街 24 号24 Tsar Asen Street, 4000 Plovdiv, Bulgaria
📞
电话Phone
+359 88 760 9808
✉️
邮箱Email
alan@suncoop.cn
🕘
工作时间Hours
周一至周五 9:00–18:00 (GMT+2)Mon–Fri 9:00–18:00 (GMT+2)
📍
保加利亚普罗夫迪夫 察尔·阿森街 24 号24 Tsar Asen Street, 4000 Plovdiv, Bulgaria
免责声明Disclaimer: 本页登记主管机构、流程与周期为基于公开资料的初稿,标注"以官方为准"。具体登记要求、周期与费用以各国官方主管部门最新规定为准,正式提交前请由专业顾问核实。本网站不构成法律或合规意见。The authorities, procedures and timelines on this page are a draft based on public sources, marked "subject to official rules". Exact requirements, timelines and fees are governed by each national authority's latest regulations and must be verified by a professional advisor before filing. This site is not legal or compliance advice.